BioSpace News Archive

Applied Health Analytics, LLC, which provides best-in-class analytics, technology and services to health systems across the United States in support of population health and value-based care arrangements with employers, published a response to a recent Journal of the American Medical Association (JAMA) article that measures the impact of employer-sponsored wellness programs.

Palatin Technologies, Inc. will announce its third quarter, fiscal year 2019 operating results on Thursday, May 9, 2019 before the open of the U.S. financial markets.

Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, confirms that the Company met with the U.S. Food & Drug Administration (FDA) on May 3, 2019 as expected.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage including spinal cord and peripheral nerve injury, today announced that in addition to trading on the TSX Venture Exchange, its common shares will commence trading today on the OTCQB Venture Market under the symbol “NGENF”.

The MagMAX Viral/Pathogen Nucleic Acid Isolation Kit is a new automation-ready kit for scalable recovery of RNA and DNA from viral particles and gram-negative bacteria.

Acacia Pharma Group plc (“Acacia Pharma”), a pharmaceutical company developing and commercialising hospital products for US and international markets, announces that it has received a second Complete Response Letter from the US Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for BARHEMSYS® (amisulpride injection).

BioTime, Inc. announced that it will report its first quarter 2019 financial and operating results on Thursday, May 9th, 2019, following the close of the U.S. financial markets.

Company will present four posters on cenobamate, an investigational antiepileptic drug

Leading Expert on Regenerative Medicine Debates Immune Response of PEEK and ZFUZE